Suppr超能文献

在健康的 80 岁老人中,胆固醇外排能力与冠状动脉钙、斑块易损性和端粒长度无关。

Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians.

机构信息

Department of Food and Drug, University of Parma, Parma, Italy.

Cardiology Division, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Cidade Universitária, Campinas, Brazil.

出版信息

J Lipid Res. 2018 Apr;59(4):714-721. doi: 10.1194/jlr.P079525. Epub 2018 Feb 7.

Abstract

Several studies have revealed that traditional risk factors are less effective in predicting CVD risk in the elderly, suggesting the need to identify new biomarkers. Here, we evaluated the association between serum cholesterol efflux capacity (CEC), an atheroprotective property of HDL recently identified as a novel marker of CVD risk, and atherosclerotic burden in a cohort of very old, healthy individuals. Serum CEC values were not significantly correlated either with calcium score or with markers of vulnerable plaque, such as positive remodeling, hypodensity, spotty calcification, or napking-ring sign. In addition, no association was detected between CEC and telomere length, a marker of biological aging that has been linked to atherosclerosis extent. Interestingly, elderly subjects presented a remarkably higher CEC (+30.2%; < 0.0001) compared with values obtained from a cohort of sex-matched, cardiovascular event-free, middle-aged individuals. In conclusion, serum CEC is not related to traditional risk factors in very old, cardiovascular event-free subjects, but has significantly higher values compared with a healthy, younger population. Whether this improved HDL functionality may represent a protective factor in CVD onset must be established in future studies.

摘要

多项研究表明,传统风险因素在预测老年人 CVD 风险方面的作用较小,这表明需要确定新的生物标志物。在这里,我们评估了血清胆固醇流出能力(CEC)与动脉粥样硬化负担之间的关系,CEC 是 HDL 的一种保护特性,最近被确定为 CVD 风险的一种新标志物,在一个非常健康的老年人队列中进行了研究。血清 CEC 值与钙评分或易损斑块标志物(如正性重构、低密度、点状钙化或 napking 环征)均无显著相关性。此外,CEC 与端粒长度(一种与动脉粥样硬化程度相关的生物老化标志物)之间也没有关联。有趣的是,与来自心血管事件无事件、年龄匹配的中年人群的数值相比,老年受试者的 CEC 显著升高(+30.2%;<0.0001)。总之,血清 CEC 与无心血管事件的非常老的、年龄匹配的受试者的传统危险因素无关,但与健康的年轻人群相比,CEC 值显著更高。这种改善的 HDL 功能是否代表 CVD 发病的保护因素,必须在未来的研究中确定。

相似文献

3
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.
Curr Opin Lipidol. 2019 Apr;30(2):101-107. doi: 10.1097/MOL.0000000000000589.
4
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):953-963. doi: 10.1161/ATVBAHA.118.310538. Epub 2018 Feb 8.
5
High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.
Atherosclerosis. 2018 Nov;278:278-285. doi: 10.1016/j.atherosclerosis.2018.09.032. Epub 2018 Sep 25.

引用本文的文献

1
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis.
Atheroscler Plus. 2021 Aug 11;44:18-24. doi: 10.1016/j.athplu.2021.08.002. eCollection 2021 Oct.
2
HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role.
Cells. 2021 Jul 23;10(8):1869. doi: 10.3390/cells10081869.
3
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
Circulation. 2021 Jun 8;143(23):2293-2309. doi: 10.1161/CIRCULATIONAHA.120.044221. Epub 2021 Jun 7.
7
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
Ther Adv Chronic Dis. 2020 Sep 28;11:2040622320959248. doi: 10.1177/2040622320959248. eCollection 2020.
8
Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis. 2020 Mar;297:81-86. doi: 10.1016/j.atherosclerosis.2020.02.007. Epub 2020 Feb 15.
9
Coagulatory Defects in Type-1 and Type-2 Diabetes.
Int J Mol Sci. 2019 Dec 16;20(24):6345. doi: 10.3390/ijms20246345.
10
Vulnerable Plaque, Characteristics, Detection, and Potential Therapies.
J Cardiovasc Dev Dis. 2019 Jul 27;6(3):26. doi: 10.3390/jcdd6030026.

本文引用的文献

3
Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.
Circ Res. 2017 Mar 31;120(7):1130-1138. doi: 10.1161/CIRCRESAHA.116.309421. Epub 2016 Dec 12.
4
Leukocyte Telomere Length in Relation to 17 Biomarkers of Cardiovascular Disease Risk: A Cross-Sectional Study of US Adults.
PLoS Med. 2016 Nov 29;13(11):e1002188. doi: 10.1371/journal.pmed.1002188. eCollection 2016 Nov.
5
Classification for Longevity Potential: The Use of Novel Biomarkers.
Front Public Health. 2016 Oct 28;4:233. doi: 10.3389/fpubh.2016.00233. eCollection 2016.
7
Cholesterol efflux capacity: An introduction for clinicians.
Am Heart J. 2016 Oct;180:54-63. doi: 10.1016/j.ahj.2016.07.005. Epub 2016 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验